Every 13F-reported equity position this quarter with its quarter-over-quarter change; each row traces to the filer's 13F-HR on EDGAR.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR
Every 13F-reported equity position this quarter with its quarter-over-quarter change; each row traces to the filer's 13F-HR on EDGAR.
KINNEVIK AB (PUBL) (CIK 1766574) reported $65.6M across 1 reported positions in its SEC 13F filing for 2025-09-30. Largest positions: RXRX ($65.6M, 100.00%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | RXRX | Recursion Pharmaceuticals, Inc. | $65.6M | 100.00% | 13.4M | Hold |
Source: SEC Form 13F filings · as of 2025-09-30